WHO世界卫生组织：2025年推荐的侵袭性非伤寒沙门氏疫苗产品特性报告（英文版）

Invasive non-typhoidal serovars of Salmonella enterica, S. Typhimurium and S. Enteritidis, (iNTS) were estimated to cause over 500 000 invasive disease illnesses associated with more than 79 000 deaths in the Institute for Health Metrics and Evaluation Global Burden of Disease Study in 2019 with a high case fatality ratio of 14.5%. Several iNTS vaccines are currently in development and could be an important new tool in the fight against invasive disease.WHO preferred product characteristics (